Literature DB >> 20180955

Progressive painless lower limbs weakness in a dialyzed patient: undiagnosed tertiary syphilis: a case report.

O Dahmani1, N Target, Jp Guy, S Belkhelfa, F Mermet Jeanvoine, J Servonnat, J Djellid.   

Abstract

INTRODUCTION: Syphilis is a sexually transmitted disease, remaining under-estimated, under-recognized due to the variability of clinical presentation and ageing of the population with chronic comorbidities. Hence, some manifestations of the past are nowadays superimposed on the course of chronic diseases. Clinical suspicion should be guided by past medical history of contracting any other sexual disease in a heterosexual person or man who has sex with man. CASE
PRESENTATION: We describe a rare case of tertiary syphilis in a hemodialyzed diabetic patient whom was career of chronic liver disease due to the evolution of chronic hepatitis B virus infection complicated by a hepatocellular carcinoma. Initial orientation in diagnosing this rare presentation of progressive painless lower limbs weakness was attributed to possible side effects of ongoing anti viral therapy including lamivudine and adefovir. We continued administering both drugs while patient notified a spectacular improvement under Ceftriaxone therapy introduced empirically for a possible chest infection. Routine ophthalmologic examination realized in a teaching hospital, scheduled without knowing the course of late infection showed the presence of a syphilitic uveitis.
CONCLUSION: This case emphasizes the need for a high index of clinical suspicion for syphilis before the occurrence of symptoms related to its end organ damage dominated by neurosyphilis form. Early diagnosis is the key to preventing significant morbidity and mortality and improving prognosis. However, in the setting of chronic diseases such as chronic kidney diseases either before setting up methods of renal replacement therapy or under immune-suppressive therapy; clinical presentation might resemble any disease, delaying the certitude of the diagnosis by prescribing a rapid plasma reagin.

Entities:  

Year:  2010        PMID: 20180955      PMCID: PMC2836290          DOI: 10.1186/1757-1626-3-23

Source DB:  PubMed          Journal:  Cases J        ISSN: 1757-1626


Introduction

Syphilis remains a common disease worldwide re-emerging as an important disease in western countries [1,2]. Untreated, during its latent phase; it could resemble any disease and escape from diagnosis unless having a high index of suspicion in a patient who contracted any other sexual transmitted diseases. Little is known about syphilis in dialyzed population. Herein, we report a hemodialyzed patient suffering from a progressive painless lower limbs weakness responding favourably to ceftriaxone therapy given initially for a possible chest infection.

Case presentation

A 63-year-old married man of Asian ethnicity, on regular haemodialysis three times weekly undergoing diabetic nephropathy for the last two years, was complaining of having walking difficulties for two months. He was known to have chronic hepatitis B liver disease staged Child A with grade I oesophageal varices under anti viral therapy including the combination of lamivudine plus adefovir adjusted to kidney function tests. He also had a history of an operated hepatocellular carcinoma. He had many diabetic degenerative complications (proliferative retinopathy, stented ischemic heart disease, peripheral neuropathy) as well. He started complaining of a symmetrical painful proximal lower limbs weakness attributed initially to lumbar root compression according to lumbar CT scan and EMG/NCS findings. The former showed diffuse degenerative changes associated with a disc protrusion at L3-L4 level. The later showed evidence of a pending left external popliteal sciatic nerve without evidence of diffuse symmetrical polyneuropathy. Symptoms were relieved by benign pain killer and gabapentin 300 mg every other day. Three months later he arrived at the emergency department with mild fever, non productive cough, nocturnal sweat and inability to walk. Physical examination revealed an ill looking patient, weighing 63 kgs with blood pressure of 154/95 mmHg, heart rate 104 bpm regular, temperature 38.2 C and oxygen saturation of 95%. Glasgow score was 15 without meningismus or oto-ocular manifestations. Proprioception was conserved and Babinski, Hoffman and Laseque signs were all negative. The patient had mild walking abnormalities, MSGS at 3/5 and very poor squat test. However, both patellar reflexes were active, and symmetric. He had no pain or peripheral numbness. Cardiovascular examination showed moderate tachycardia without friction rub or murmurs. There were bi-basal crackles mostly on the right side with absence of dullness on percussion and hepatojugular reflux. The peripheral pulse was conserved without acrosyndrom. Skin examination showed pityriasis versicolor-like eruptions mainly on upper limbs and upper thorax. The external genitalia revealed hypochromic vitiligoid spots on the scrotum. He was free of lymphadenopathy. Results of laboratory investigations are shown in tables 1, 2 and 3. Sputum smear for bacterial and mycobacterium, urine C/S, blood C/S (3), Mantoux test, were all negative. iPTH = 205 ng/l (15-65), 1, 25(OH) D3 24 pmol/l (43 - 148) and 25 OH D3 = 38 nmol/l (75 - 200) with normal phosphocalcic product. VDRL = 2, TPHA 1280, FTA abs 100, FTA -M <10 and positive anti -TpN47, TmpA, TpN17 and TpN 15(IgG western-blot). EKG showed no new changes and transthoracic Doppler-echocardiography demonstrated normal left ventricular size and function apart from mild concentric hypertrophy. He had no significant valvulopathy, though a calcified bicuspid aortic valve with mild regurgitation was noted without Aortitis or aneurismal aspects. CXR disclosed an interstitial aspect of both field of the lungs and normal sized mediastinal silhouette. Funduscopic appearance showed beside proliferative retinopathy, a syphilitic uveitis thereafter, discovered incidentally elsewhere. Abdominal and pelvis ultrasound study demonstrated mild splenomegaly and poorly differentiated normal sized kidneys with acquired cystic disease. The patient received an empirical treatment of ceftriaxone 1.5 gr administered post-dialysis with a spectacular response within one week; therapy judged by net improvement of his weakness and return home walking. Ceftriaxone alone was maintained to complete duration of two weeks. Meanwhile, the spouse of the patient was convoked for screening. We learned that she had been receiving prednisolone and sub-cutaneous injection of infliximab weekly for the last six months, and ibuprofen for a relapsing rheumatoid arthritis. Awaited syphilitic serologic testing disclosed normal blood chemistry without inflammation (CRP = 5 mg/l). VDRL = 2, TPPA = 2560 FTA abs 200, FTA-M 20 (N <10). A medical report was sent to her general practitioner for intramuscular Benzathin-penicillin therapy 2.4 Millions units weekly over three consecutive weeks.
Table 1

Results of haematology laboratory tests

VariablePatientNormal range
Haemoglobin (gr/dl)1013 - 17
Hematocrit (%)29.840 - 54
White cell count (per mm3)10 0004 000 - 10 000
Differential count:
 Neutrophils8500
 Lymphocytes760
 Monocytes670
 Eosinophils50
 basophils20
Platelets count (per mm3)193000150 000 - 350 000
Mean corpuscular volume(fl)94.480 - 100
Prothrombin time (%)9170 - 100
International normalized ratio1.07
Partial thromboplastin time activated (sec); P/C55/32
Fibrinogen (gr/l)5.62.5 - 4
D-dimmers (mcg/l)0.80.5
CRP (mg/l)48< 5
Procalcitonin (mcg/l)0.66<0.5
Orosomucoid level (gr/l)1.620.57 - 1.22
Haptoglobin (g/l)2.790.87 - 2.32
Transferring (g/l)2.041.77 - 2.83
Beta 2 microglobulin (mg/l)10.401 - 2

gr/dl = gram per decilitre, mg/l = milligram per litre, mcg = microgram per litre, P/C = patient/control

Table 2

Results of blood chemistry tests

VariablePatientNormal range
Glucose (mmol/l)7.13.1 - 6.4
HbA1c (%)6.4< 7 in diabetic patients
Urea nitrogen (mmol/l)21.91.7 - 8.3
Creatinine (umol/l)501< 106
Calcium (mmo/l)2.032.15 - 2.55
Phosphorus (mmol/l)1.380.87 - 1.45
Sodium (mmol/l)138136 - 145
Potassium (mmo/l)4.63.5 - 5.1
Chloride (mmol/l)9995 - 105
Carbon dioxide (mmol/l)1823 - 29
Total Bilirubin (umol/l)10< 22
Alanine aminotranferase14< 41 UI/l
Aspartate aminotransferase46< 37 UI/l
Alkaline phosphatise902< 270 UI/l
Gamma glutamyl transferase476< 49 UI/l
Lactate dehydrogenase417< 480 UI/l
Amylase173< 220 UI/l
Creatine kinase113< 190 UI/l
Lactic acid (mmol/l)0.76< 2
Iron (umol/l)16.510.7 - 32
Iron binding capacity(umol/l)4645 - 72
Transferrin saturation coefficient (%)0.360.15 - 40
Ferritin (ng/ml)898.530 - 240
Ammonia (umol/l)8816 - 60
Plasma osmolarity (moSm/l)315275 - 305
Uric acid (umol/l)276< 420

Mmol/l = millimol per litre, μmol/l = micromol per litre, mosm/l = milliosmol per litre, ng/ml = nanogram per millilitre

Table 3

Results of immunology laboratory tests

VariablePatientNormal range
Antinuclear antibody (Abs)< 1:80> 1: 80
Anti DNA AbsNegative
Rheumatoid factorNegative
Antineutrophil cytoplasmic Abs
 Anti PR3 abs< 10< 20
 Anti MPO abs< 10< 20
Complement
  TotalN/A
  C31.60.90 - 1.73
  C4N/A
IgG14.46.5 - 12.08
IgA2.921 - 3.20
IgM0.520.49 - 1.38
CryoglobulinNEGATIVE
Anticardiolipin Abs< 10< 23
HCV Absnegative
HbsAgpositive
HbsAbs<5
HbcAbs
IgGpositive
IgMnegative
HIV 1 & 2negative
Thyroid function testlow T3 with normal TSH
Chlamydia (Ig M)< 10< 10
Mycoplasma (Ig M)negative
Legionella urinary Agnegative
Lyme disease (IgM)negative
Plasma protein electrophoresis
  Total proteins(g/l)7466 - 87
  Albumin (g/l)37.436 - 48
  Alpha 1 (g/l)31 - 3
  Alpha 2 (g/l)11.44 - 8
  Beta (g/l)9.25 - 10
  Gamma (g/l)12.97 - 13
  A/G ratio:1.02
Folic acid level (nmol/l)9> 7
B12 vitamin level (pmol)477133 - 675

Abs = antibodies, Ag = antigen, pmol/l = picomol per litre

Results of haematology laboratory tests gr/dl = gram per decilitre, mg/l = milligram per litre, mcg = microgram per litre, P/C = patient/control Results of blood chemistry tests Mmol/l = millimol per litre, μmol/l = micromol per litre, mosm/l = milliosmol per litre, ng/ml = nanogram per millilitre Results of immunology laboratory tests Abs = antibodies, Ag = antigen, pmol/l = picomol per litre

Discussion

The diagnosis of late latent syphilis is very difficult to make because of the diversity and similarity of its clinical presentation [1,3]. In fact, Sir William Osler stated that "syphilis simulates every other disease" owing to mixed and atypical forms. Besides having a high index of suspicion; past medical history of exposure to Treponema pallidum, and physical examination along with serologic tests remained paramount for the diagnosis. Cerebrospinal fluid (CSF) may be helpful, though neurosyphilis with normal CSF cell count in a HIV negative subject has been reported [4]. In addition a negative CSF VDRL cannot exclude it, and FTA-Abs is less specific, but more sensitive. In our case the diagnosis was difficult because of superimposed other diseases which unmasked its latent form by impairing immunity: complicated diabetes mellitus, Chronic HBV infection under anti-viral therapy, end stage renal failure and therapeutic agents prescribed for dialyzed patients. However, the diagnosis of tertiary syphilis has been guided by previous history of contracting sexually HbsAg and the slowly progressive proximal lower limbs weakness, associated with skin eruptions, pneumonitis and cholestatic hepatitis. Uveitis was diagnosed in another hospital without knowing the syphilitic course. Pulmonary involvement in our case filled the criteria proposed by Coleman et al [5], and ceftriaxone therapy was initially given empirically. The decision to continue ceftriaxone over two weeks was based on positive serologic tests. Shan et al [6], described a case of successful treatment of symptomatic neurosyphilis with ceftriaxone, as in ours. Echocardiography finding of calcified bicuspid Aortic valve might be a consequence of either syphilis, or secondary hyperparathyroidism, or both. The neurological signs and symptoms presented herein might evoke a picture similar to that of chronic myelopathy in which the pyramidal pathway is involved, characterized by active reflexes and positive Babinski's sign. This latter was negative probably due to peripheral polyneuropathy that was not confirmed by either physical examination or on EMG/NCS registering. A combined neuro-muscular syphilitic affection remained the most likely in addition to a painful radiculopathy abolished by pain killers. However, we can not exclude syphilitic spinal cord involvement by simple CT scan finding. EL Quessar et al [7], reported a case of spinal cord gumma with normal myelography and Brain CT. We didn't perform lumbar puncture or further explorations due to rapid clinical improvement under ceftriaxone therapy and antiviral drugs have been continued.

Conclusion

Syphilis remains a great imitator because its signs and symptoms are not pathognomonic when superimposed upon chronic diseases yielding high morbidity. Keeping high grade of suspicion of syphilis in individual who are at risk of other sexually transmitted infection and vice-versa is mandatory to limit syphilitic end organ damage. In hemodialyzed patients ceftriaxone is gaining ground when treating acquired syphilis and is equivalent to benzathin penicillin not only because of its practical administration but due to impaired pharmacokinetics of the latter. The rule in treating the sex partner of an infected patient regardless of whether or not infected should be respected as in ours.

Abbreviations

EMG/NCS: electomyogram test/nerve conduction studies; MSGS: muscle straight grading scale; VDRL: venereal disease reference laboratory; TPHA: treponema pallidum haemagglutination assay; FTA abs: florescent treponemal antibody-absorption test; C/S: culture and sensitivity; CXR: chest x-ray; EKG: electrocardiogram; iPTH: intact parathyroid hormone; HBV: hepatitis B virus; HCV: hepatitis C virus.

Consent

Written informed consent was obtained from the patient for submission of manuscript for publication of this case. A copy of the consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

All authors contributed to each stage of this work, OD, NT, JPG, SB, FMJ, JS and JD all have: (1) made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; (2) been involved in drafting and revising the manuscript; and (3) given final approval of the version to be published.
  7 in total

1.  [Syphilitic spinal cord gumma].

Authors:  A El Quessar; R El Hassani; N Chakir; M Jiddane; N Boukhrissi
Journal:  J Neuroradiol       Date:  2000-09       Impact factor: 3.447

2.  Treatment of neurosyphilis with ceftriaxone.

Authors:  S Shann; J Wilson
Journal:  Sex Transm Infect       Date:  2003-10       Impact factor: 3.519

Review 3.  Secondary syphilitic lesions.

Authors:  Robert E Baughn; Daniel M Musher
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  [Epidemiological and clinical aspects of neurosyphilis in Morocco].

Authors:  M Yahyaoui; S Serragui; W Regragui; L Errguig; O Mouti; A Benomar; T Chkili
Journal:  East Mediterr Health J       Date:  2005-05       Impact factor: 1.628

Review 5.  Syphilis.

Authors:  Patrick French
Journal:  BMJ       Date:  2007-01-20

6.  Secondary syphilis with pulmonary involvement.

Authors:  D L Coleman; S J McPhee; T F Ross; J L Naughton
Journal:  West J Med       Date:  1983-06

7.  Neurosyphilis in a young adult: very early tertiary syphilis?

Authors:  Sergio Sabbatani; Roberto Manfredi; Francesco Chiodo
Journal:  Int J STD AIDS       Date:  2005-12       Impact factor: 1.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.